NEW YORK A near doubling in the diabetes population and near tripling in costs of treating the disease threatens to create a huge drag on the healthcare system and the economy as a whole, but retail pharmacies have the opportunity to help bring some of those costs down.
A study commissioned by Danish drug maker Novo Nordisk forecasts that by 2034, the American diabetes population will be 44.1 million, while spending on the disease will total $336 billion.
